The role of Helicobacter pylori in the chronic gastritis and stomach cancer formation: international guidelines review and own research results

Therapy ◽  
2020 ◽  
Vol 4_2020 ◽  
pp. 102-109
Author(s):  
Luzina E.V. Luzina ◽  
Chartorizhskaya N.N. Chartorizhskaya ◽  
Melnikov V.V. Melnikov ◽  
Lareva N.V. Lareva ◽  
◽  
...  
2019 ◽  
Vol 44 (3) ◽  
pp. 54-61
Author(s):  
Y. S. Tsimmerman ◽  
Yu. A. Zakharova

The article defines chronic gastritis as a polyetiological and polypathogenetic stomach disease with a chronic, slowly progressing course, which is based on a specific inflammatory process with lymphoplasmocytic infiltration of its mucosa and neutrophilic component indicating its activity, and with development of disregenerative, dystrophic changes, leading to its secretory insufficiency, manifested hypo- and achlorhydria and gastric achilia. The history of studying chronic gastritis from the beginning of the 19th century till present days is briefly described. It is proposed to distinguish between causal (Helicobacter pylori, etc.) and predisposing (alcohol, smoking, coarse food, etc.) factors in the development of chronic gastritis. The analysis of various classifications of gastritis is carried out: based on etiology, pathogenesis, functional features, clinic, endoscopic and histological characteristics. The Sydney, Houston classifications, the OLGA system are described. Particular attention is paid to diagnosis, biopsy technique of the gastric mucosa, ratio of diagnoses of chronic gastritis and functional dyspepsia, as well as the role of gastric microflora in development of gastritis. It is revealed that gastric microflora in chronic gastritis is represented by numerous types of bacteria (more often in the form of bacterial associations), moreover, Helicobacter pylori is not the dominant microorganism colonizing the stomach, and the mucosal microflora found in the stomach has adhesiveness, invasiveness and pathogenic properties, including its urease activity.


Doctor Ru ◽  
2020 ◽  
Vol 19 (7) ◽  
pp. 49-51
Author(s):  
A.V. Vasyutin ◽  
◽  
Yu.L. Tonkikh ◽  
V.V. Tsukanov ◽  
◽  
...  

Objective of the Review: to analyse new information on the role of microbiome in stomach cancer development. Key Points. Study of microbiome in stomach cancer patients is one of the actively developing areas of modern medicine. Study results are very ambiguous and sisputable. Sequencing of 16S ribosomal ribonucleic acid made it possible to study microorganisms that colonise the stomach, which could not be studied with other methods. It allowed identifying a number of gastric bacteria and study their role in pathology. Conclusion. Most likely there will appear new information confirming the role of dysbiosis in gastric carcinogenesis. Keywords: microbiome, dysbiosis, stomach cancer, gastritis, Helicobacter pylori.


Gene Reports ◽  
2022 ◽  
pp. 101500
Author(s):  
Haneen Mohammed Reda Jaber Alhasnawi ◽  
Ahmed Abduljabbar Jaloob Aljanaby

2017 ◽  
Vol 95 (2) ◽  
pp. 181-188
Author(s):  
Yakov S. Tsimmerman ◽  
Yu. A. Zakharova

The main provisions and headings of the new etiological classification of chronic gastritis are discussed in the context of recent data on the true role of Helicobacter pylori infection in the development of this pathology. The methods and results of the authors ’ investigations into gastric microflora are presented along with information about the frequency of detection of its different forms, concentration of microbial forms in gastric mucosa, their pathogenic properties including urease activity, and possible contribution to chronic gastritis etiology. The possibility of alcoholic and chemical chronic gastritis is discussed along with the role of these conditions in the development of stomach cancer. Special emphasis is laid on the disagreement between the adopted consensuses and principles of evidence-based medicine.


1997 ◽  
Vol 13 (suppl 1) ◽  
pp. S15-S25 ◽  
Author(s):  
Karen J. Goodman

Accumulating evidence has implicated Helicobacter pylori, an established cause of chronic gastritis and peptic ulcer, in the etiology of gastric cancer. Control of this infection would reduce the occurrence of chronic gastritis and peptic ulcer and might substantially lower the risk of stomach cancer as well. The public health impact of this infectious agent warrants efforts to identify preventive measures. This paper reviews the evidence linking H. pylori infection to gastric cancer and evaluates the potential for control in high-risk populations. Current obstacles to H. pylori control are discussed, including the link to poor socioeconomic conditions, difficulty in identifying incident cases, lack of natural immunity to reinfection, limited effectiveness of antibiotic therapy in high-prevalence populations, and incomplete knowledge regarding the reservoir of infection, mode of transmission, host susceptibility factors, and the potential for developing an effective vaccine. Worthwhile avenues of research include studies designed to identify modifiable risk factors for acquisition of the infection, modifiable host factors that may increase resistance to chronic infection, more effective antibiotic therapies, and effective vaccines.


2018 ◽  
Vol 9 (1) ◽  
pp. 77-83 ◽  
Author(s):  
Yury P. Uspenskiy ◽  
Natalia V. Baryshnikova

Diseases of upper parts of digestive tract are extremely widespread pathology and have not only the medical, but also social importance since often occur at young working-age people. It is actual to separate the items: functional dyspepsia (FD) and a dyspepsia associated with Helicobacter pylori because it is important for optimization of patient’s treatment. The review of modern foreign and Russian references about treatment of dyspeptic patients depending on existence or absence of an infection of Helicobacter pylori is presented in article (recommendation of V Maastricht consensus, Kyoto consensus, Russian gastroenterological association, Science society of Russian gastroenterologists). At diagnosis of a functional dyspepsia, it is recommended to be guided by the Roman criteria of the IV revision. In with document not only importance of an exception of organic pathology of digestive tract as the reasons of a secondary dyspepsia, but also need of inspection for the purpose of verification of Helicobacter pylori for an exception of an etiological role of a microorganism in development of a dyspepsia is emphasized. Allocation of two clinical options of a functional dyspepsia is also proved from the point of view of approaches to therapy of this disease. Algorithms of treatment of patients with various options of a dyspepsia are presented in article. These algorithms include different schemes of eradication therapy in case of dyspepsia associated with Helicobacter pylori and prokinetics/acid suppressors in case of functional dyspepsia.


Sign in / Sign up

Export Citation Format

Share Document